Glioblastoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Active, not recruiting
  • High Grade Glioma
  • +3 more
  • Regadenoson 0.05mg
  • +6 more
  • Birmingham, Alabama
  • +2 more
2022-04-07
Apr 7, 2022
N
Recruiting
  • Gliosarcoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
G
Recruiting
  • Glioblastoma
  • Birmingham, Alabama
  • +47 more
2022-04-06
Apr 6, 2022
I
Active, not recruiting
  • Glioblastoma
  • INO-5401
  • +4 more
  • Duarte, California
  • +20 more
2022-04-06
Apr 6, 2022
N
Active, not recruiting
  • Glioblastoma
  • Los Angeles, California
  • +13 more
2022-04-07
Apr 7, 2022
B
Recruiting
  • Glioblastoma
  • MGMT-Unmethylated Glioblastoma
  • Microtubule-Targeted Agent BAL101553
  • +3 more
  • Birmingham, Alabama
  • +7 more
2022-03-31
Mar 31, 2022
M
Completed
  • Glioblastoma
  • Avastin
  • +5 more
  • Boston, Massachusetts
    Massachusetts general Hospital
2022-04-06
Apr 6, 2022
U
Terminated
  • Glioblastoma Multiforme
  • +3 more
  • Gainesville, Florida
  • +1 more
2022-03-31
Mar 31, 2022
N
Recruiting
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Costa Mesa, California
  • +49 more
2022-04-06
Apr 6, 2022
S
Active, not recruiting
  • Glioblastoma
  • Birmingham, Alabama
  • +60 more
2022-04-04
Apr 4, 2022
M
Recruiting
  • Glioblastoma
  • +2 more
  • External Beam Radiation Therapy
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2022-04-04
Apr 4, 2022
C
Recruiting
  • Glioblastoma
    • Dijon, France
    • +4 more
    2022-03-24
    Mar 24, 2022
    W
    Recruiting
    • Glioblastoma
    • Personalized neoantigen DNA vaccine supplied by Geneos Therapeutics
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    2022-03-21
    Mar 21, 2022
    S
    Recruiting
    • Anaplastic Astrocytoma
    • +55 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    2022-04-01
    Apr 1, 2022
    S
    Recruiting
    • Diffuse Midline Glioma (DMG)
    • +6 more
    • ONC206
    • Standard of Care Radiation Therapy
    • San Francisco, California
    • +2 more
    2022-03-30
    Mar 30, 2022
    T
    Recruiting
    • Ependymoma
    • +3 more
    • Augusta, Georgia
      Augusta University, Georgia Cancer Center
    2022-03-20
    Mar 20, 2022
    S
    Active, not recruiting
    • High Grade Glioma
    • +6 more
    • Birmingham, Alabama
    • +5 more
    2022-03-31
    Mar 31, 2022
    A
    Recruiting
    • Glioblastoma
    • Radation Therapy
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    2022-03-31
    Mar 31, 2022
    P
    Not yet recruiting
    • Glioblastoma
    • (no location specified)
    2022-03-30
    Mar 30, 2022
    N
    Recruiting
    • Glioblastoma
    • +3 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Birmingham, Alabama
    • +9 more
    2022-03-30
    Mar 30, 2022
    X
    Recruiting
    • Glioblastoma
    • +3 more
    • Radiation: Intra-operative Radiation Therapy - IORT
    • +2 more
    • Santa Monica, California
      Providence Saint John's Health Center
    2022-03-30
    Mar 30, 2022